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Abstract 
Performed integral estimation of the diagnostic value of the obtained clinical-
paraclinical parameters is indicative of a sufficient amount of reliable markers in verification of 
severe bronchial asthma (BA) in children. Children with severe bronchial asthma are 
characterized by the following phenotype peculiarities: early debut of the disease (chance ratio 
(CR) = 1,5 (95% confidence interval (CI) 0,9-2,7), comorbid allergic diseases available 
(allergic rhinitis and atopic dermatitis) (CR 2,7 (95% CI 1,5-4,8) and drug-induced or 
comorbid drug-induced and food or domestic allergy (CR=4,8 (95% CІ 0,1-36,5)), infectious 
index more than 2 (CR=3,3 (95% CІ 1,6-6,7), seasonal exacerbation of BA mainly from 
November to March (СR=2,7 (95% CІ 1,5-4,9), associated with a trigger role of acute 
respiratory viral infection (ARVI) (СR=5,5 (95% CІ 2,4-12,6) and meteorological factors 
(СR=3,8 (95% CІ 0,4-36,4). 
Key words: children, bronchial asthma, clinical-anamnestic indices, sensitivity, 
specificity.  
 
Introduction. Severe bronchial asthma (BA) today is an extremely topical problem 
for a pediatrician. Severe BA in children as well as in adults progresses with frequent 
exacerbations, a considerable decrease of functional signs of the lungs and quality of life of 
patients [3, 4]. Its spread among children is 1:1000, and predominantly children older than 10 
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suffer from it [8]. The quality of life decreases most considerably among the patients with 
severe and especially severe uncontrolled progress of BA. The data presented explain the 
necessity to find possible predictors of severe BA as well as detect clear clinical criteria of its 
verification. 
One of the possible approaches in detection of factors being predictors of a severe 
progress of the disease is a comparative characteristic of patients with severe and moderate 
progress of BA on the basis of a standardized set of signs [10, 13]. Both Ukrainian and 
international authorities emphasize a leading role of clinical-anamnestic criteria in diagnostics 
of BA and detection of therapeutic approaches [6, 12, 13]. 
Analysis of clinical-anamnestic indices in children with the signs of BA will enable a 
physician to optimize early verification of a severe progress of BA, promote the efficacy of 
treatment and improve the diagnostics.  
Objective: to analyze a diagnostic value of clinical-anamnestic indices of severe BA 
in comparison with a moderate variant of the disease. 
Materials and methods. To achieve the purpose of the study 60 schoolchildren 
suffering from BA were examined at the Pulmonological Department of the Regional 
Children Clinical Hospital in Chernivtsi. Depending on the severity of persistence the disease 
of children was distributed into two clinical groups. The first clinical group (І) included 30 
children with the phenotype of severe BA, the second one (ІІ) included 30 children with a 
moderate variant of BA. According to the main clinical signs the groups of comparison did 
not differ reliably (Table 1). 
Table1 
General characteristic of the comparison groups 
Indices  Clinical groups Р 
І (n=30)  ІІ (n=30)  
Average age, years (M±m)  12,2±0,54 11,1±0,59  >0,05  
Boys (%, Р±m)  66,7±8,6%  64,3±8,9%  > 0,05  
Rural residents (%, Р±m)  66,7±8,6%  60,7±8,9%  > 0,05  
 
The study employed clinical-anamnestic method, BA classification according to the 
protocol of diagnostics and treatment of BA in children approved by the Ministry of Public 
Health of Ukraine [6], as well as according to International Global Initiative concerning the 
diagnostics and treatment of BA (GINA) [11]. Aggravation of family anamnesis by atopic 
diseases and bronchial asthma was evaluated by genealogic index (GI) [5].  
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The results of the study obtained were analyzed by means of the computer packages 
«STATISTICA» StatSoft Inc. and Excel XP for Windows on a personal computer using 
parametric and non-parametric calculation methods and from the point of view of clinical 
epidemiology. To estimate diagnostic value of the tests the following indices were determined: 
test susceptibility, test specificity, prognostic value of a positive result (PVPR) and prognostic 
value of a negative result (PVNR). The risk of the event realization was estimated considering 
the probability of chance ratio (CR) and detection of their confidence intervals (95% CІ) [14]. 
Results of the study and their discussion. Taking into account a multi-factor nature of 
BA anamnestic peculiarities of the examined children were considered to be reasonable to be 
analyzed. The disease debut estimation in the groups of comparison demonstrated that in the 
group of children with severe progress of BA the patients with so-called “asthma of an early 
onset” prevailed, which was diagnosed in 53,3% against 42,9% (Р>0,05) cases of the 
compared group, although without statistical confidence.  
Only the patients born after then third and following it labour were found among those 
with severe BA, which was associated with a high risk of frequent episodes of acute 
respiratory diseases, possessing both initial and protector effect concerning BA progress [9]. 
Thus, infectious index more than 2,0 was found in 33,3% patients with severe BA against 
13,2%  patients of the compared group (Pφ<0,05).  
Aggravation of individual allergy anamnesis was registered more often in the group of 
children with severe BA. The signs of allergic rhinitis and atopic dermatitis were found in 21 
children (70,0±8,3%) of the І clinical group and in 13 schoolchildren (46,4±9,1%) of the  
compared group (Pφ<0,05). At the same time, the phenotype of severe asthma was associated 
with drug-induced or combined (drug-induced and food or domestic) allergy: in every fifth 
(24,2±6,0%) patient against every case in the compared group (Р<0,05).  
It should be noted that genealogical index (GI) in case of available allergic diseases in 
the families of patients from the groups of comparison did not differ much. Thus, an average 
GI in the I group was 0,17 standard units (s.u.) and 0,16 s.u. in the II group. Although GI 
more than 0,16 s.u. was registered in children with severe asthma in 50,0% of cases against 
28,6% of the observations (Pφ<0,05) in the compared group. 
Analysis of clinical signs of BA during a year among children from the groups of 
comparison demonstrated that severe asthma is characterized by seasonal exacerbations 
contrary to a moderate progress of asthma corresponding to the findings of the studies [1].  
Thus, association of exacerbations with seasonal character was found in 87,0% of children 
suffering from severe BA as compared to 69,2% of patients from the II clinical group 
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(Pφ>0,05). At the same time, the majority of seasonal exacerbations of BA (60,9% of cases) 
among the patients from the I clinical group occurred in a cold season of the year (November-
March) contrary to the II clinical group, where exacerbations in this season of the year 
occurred only among the third of patients (36,3% of cases) (Pφ<0,05). 
The indicated seasonal character of aggravation of the clinical progress of severe BA 
usually was associated with prevailing non-specific trigger exacerbation factors (ARVI 
against the ground of increased atmospheric humidity and low temperature) [2]. Thus, the 
challenge of BA exacerbations in the I group was associated with a trigger role of ARVI in 
33,3% cases and meteorological factors in 23,8% children against 8,3% cases (Рφ<0,01) and 
none of the cases (Рφ<0,01) in the II group respectively. 
As to the clinical peculiarities of the disease progress daily symptoms of the disease 
with the frequency more than once a week were found in children with severe asthma in 
36,0±8,7% of cases against 10,5±5,5% (Р<0,05) of observations among the patients with a 
moderate progress of BA. This cohort of patients was characterized by severe restriction of 
physical activity in 28,0±8,1% of cases against 5,2±4,0% (Р<0,05) of children from the II 
clinical group. Correspondingly, they were characterized by the frequency of admission to the 
hospital 4-5 times a year in 24,0±7,7% of cases (Р<0,01), frequency of β2-agonists necessary 
administration more than four doses a day in 16,0±6,6% (Р<0,05) of cases against no one 
from the II clinical group. 
Monthly exacerbations of BA occurred in the representative of the I group in 
36,0±8,7% of cases against 15,7±6,6% (Рφ<0,05) in the II clinical group. The frequency of 
unplanned visits to the allergist more than once a month was found in 20,0±7,3% (Рt<0,05) of 
severe asthma cases against no one in the compared group.   
Considering the data obtained clinical-epidemiological analysis of the results of 
examination of children with severe asthma phenotype was carried out. Table 2 presents the 
indices of the diagnostic value of clinical-anamnestic indices in verification of severe BA 
phenotype as compared to its moderate variant.  
Clinical-epidemiological analysis conducted in verification of severe asthma 
demonstrated a low susceptibility of these indices due to false negative results available 
within the limits of 29,2-76,2%. Specificity of certain criteria appeared to be rather high 
except early debut of the disease in anamnesis, the signs of comorbid allergic diseases, 
seasonal exacerbations, aggravated genealogical anamnesis according to allergic diseases 




Diagnostic and prognostic value of clinical-paraclinical markers of severe  









Positive  Negative 
Early debut of the disease 53,3 67,1 71,7 55,0 1,5 
Infectious index 2 and > 33,0 87,2 71,7 56,5 3,3 
Comorbid allergic diseases 
available 
70,3 54,7 60,3 64,3 2,7 
Drug-induced or combined 
drug-induced and food or 
domestic allergy available 
27,6 90,3 83,3 42,9 4,8 
Genealogical index 50,4 72,4 49,3 59,0 2,6 
Seasonal character 61,1 64,2 48,1 62,1 2,7 
Trigger role of ARVI 33,3 91,7 80,1 57,9 5,5 
Trigger role of 
meteorological factors 
23,8 92,3 83,3 42,9 3,8 
Daily symptoms of BA more 
than 1 a week 
36,0 90,2 78,3 58,4 5,0 
Restricted physical activity 28,3 95,3 72,4 56,9 7,4 
Monthly frequency of 
exacerbations 
36,2 85,1 70,6 57,0 3,2 
 
Therefore, an integral estimation of diagnostic value of the examined clinical-
anamnestic parameters is indicative of a sufficient amount of reliable markers in verification of 
severe BA in children. The risk of its diagnostics was reliably increased by higher infectious 
index, drug-induced or combined drug-induced and food or domestic allergy available, a trigger 
role of ARVI and meteorological factors in provoked exacerbations of BA, daily symptoms of 
BA available more than once a week, restricted physical activity and monthly frequency of 
exacerbations. 
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Conclusion. Therefore, the risk of diagnostics of severe bronchial asthma in children is 
ensured by a number of clinical-anamnestic parameters, which consideration in clinical 
practical work may be effectively used in detection of tactics of a controlled treatment.  
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